Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Internet-Based Strategic Transdisciplinary Approach To Risk Reduction And Treatment (I-START)
This study is currently recruiting participants.
Verified by University Health Network, Toronto, December 2008
Sponsors and Collaborators: University Health Network, Toronto
Canadian Stroke Network
Information provided by: University Health Network, Toronto
ClinicalTrials.gov Identifier: NCT00815477
  Purpose

I-START is a randomized controlled trial that will evaluate the efficacy of an internet-based program of behavioural counseling for adaptive lifestyle change to subjects diagnosed with hypertension. I-START will be evaluated using objective outcome indices: systolic and diastolic blood pressure, pulse pressure, and markers of vagal-heart rate (HR) modulation and baroreflex sensitivity. The Heart and Stroke Foundation of Canada "Blood Pressure Action Plan(TM)" (BPAP) will be adminisered over a 4-month period, and evaluated in a 2 (Intervention vs. Wait list Control) X 2 (Baseline vs. Post-Intervention) factorial design, blocking for 3 recruitment sites (Toronto, London, the Grey Bruce region of Ontario, Canada), and stratified for sex and age group (45-59, 60-74 years).


Condition Intervention
Hypertension
Behavioral: Web-based lifestyle counseling messages
Behavioral: Generic Information

MedlinePlus related topics: High Blood Pressure
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study
Official Title: I-START: Internet-Based Strategic Transdisciplinay Approach to Risk Reduction And Treatment

Further study details as provided by University Health Network, Toronto:

Primary Outcome Measures:
  • Lifestyle Behavior: exercise and diet [ Time Frame: 4 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Laboratory assessment of blood pressure (SBP, DBP, PP) [ Time Frame: 4 months ] [ Designated as safety issue: No ]
  • laboratory assessment of estimated vagal-heart rate modulation and baroreflex sensitivity [ Time Frame: 4 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 500
Study Start Date: September 2007
Estimated Study Completion Date: July 2009
Estimated Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Active Comparator
Waitlist control with generic Information about lifestyle and hypertension
Behavioral: Generic Information
Waitlist control plus educational material on lifestyle behavior and hyptertension
2: Experimental
Web-based intervention of lifestyle counseling messages based on the transtheoretical model of readiness for change.
Behavioral: Web-based lifestyle counseling messages
10 email messages based on readiness-to-change over a 4 month period

  Eligibility

Ages Eligible for Study:   46 Years to 74 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Stage 1 OR Stage 2 hypertension
  • 46 -74 years of age
  • able to read & write English or French
  • living in private residence

Exclusion Criteria:

  • Cardiovascular disease
  • Major psychiatric disorder (e.g. psychosis)
  • Dependence on Alcohol or Drugs with in past year
  • Diabetes >= 5 years
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00815477

Contacts
Contact: Adriana Mechetiuc, M.D., Ph.D. 416-340-4800 ext 6038 adriana.mechetiuc@uhn.on.ca

Locations
Canada, Ontario
Toronto General Hospital Recruiting
Toronto, Ontario, Canada, M5G 2C4
Contact: Adriana Mechetiuc, M.D., Ph.D.     416-340-4800 ext 6038     adriana.mechetiuc@uhn.on.ca    
Principal Investigator: Robert P. Nolan, Ph.D.            
Grey Bruce Public Health Unit Recruiting
Owen Sound, Ontario, Canada, N4K 4K5
Contact: Cathy Coburn, BSn Nursing         ccoburn@publichealthgreybruce.on.ca    
Principal Investigator: Hazel Lynn, M.D.            
University of Western Ontario Recruiting
London, Ontario, Canada, N6A 3K7
Contact: Arlene Fleischhauer, BSc.N.     519-661-2111 ext 85759     afleisc@uwo.ca    
Principal Investigator: Kevin J Shoemaker, Ph.D.            
Sponsors and Collaborators
University Health Network, Toronto
Canadian Stroke Network
Investigators
Principal Investigator: Robert P Nolan, Ph.D. University Health Network, Toronto
  More Information

Responsible Party: University Health Network ( Robert P. Nolan/Director Behavioural Cardiology Research Unit )
Study ID Numbers: 06-0422-BE, Candian Stroke Network
Study First Received: December 29, 2008
Last Updated: December 29, 2008
ClinicalTrials.gov Identifier: NCT00815477  
Health Authority: Canada: Ethics Review Committee

Study placed in the following topic categories:
Vascular Diseases
Hypertension

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 15, 2009